NCT00519506View on ClinicalTrials.gov

A Phase II Study to Evaluate the Efficacy of ThromboView® in the Detection of Pulmonary Emboli

PHASE2CompletedINTERVENTIONAL
Enrollment

61

Participants

Timeline

Start Date

September 30, 2007

Primary Completion Date

June 30, 2008

Study Completion Date

October 31, 2008

Conditions
Acute Pulmonary Embolism
Interventions
OTHER

ThromboView

Radiopharmaceutical, single dose, of the diagnosis of venous thromboembolism

Trial Locations (6)

48202

Henry Forde Hospital, Detroit

63110

Washington University School of Medicine at St. Louis, St Louis

95817

UC Davis Medical Center, Sacramento

92103-3872

UCSD Medical Center, San Diego

L8N3Z5

McMaster University Medical Center, Hamilton

LBN4A6

St. Joseph's Hospital, Hamilton

Sponsors

Lead Sponsor

Agen Biomedical
All Listed Sponsors
lead

Agen Biomedical

INDUSTRY

NCT00519506 - A Phase II Study to Evaluate the Efficacy of ThromboView® in the Detection of Pulmonary Emboli | Biotech Hunter | Biotech Hunter